Order
    
    254897-50-2
    
      4,4'-(1,4-Phenylenedi-2,1-Ethenedily)Bis[N-(2-Ethyl-6-Methylphenyl)-N-Phenyl-Benzenamine
    
  
  
  
    
    
    
    
    
    
    
      
        Order
      
      33839-43-9
      
        N~2~,N~2~-diethyl-N-{2-(naphthalen-1-yl)-4-(piperidin-1-yl)-2-[2-(piperidin-1-yl)ethyl]butyl}glycinamide
      
    
    
      
        Order
      
      338396-74-0
      
        Propanedioic acid,2-[5,7-bis(trifluoromethyl)-1,8-naphthyridin-2-yl]-, 1,3-diethyl ester
      
    
    
    
    
    
    
    
      
        Order
      
      33839-48-4
      
        N~2~,N~2~-diethyl-N-[2-methyl-2-(naphthalen-1-yl)-4-(piperidin-1-yl)butyl]glycinamide
      
    
    
      
        Order
      
      33839-93-9
      
        N~2~,N~2~-diethyl-N-{3-methyl-2-(naphthalen-1-yl)-2-[3-(piperidin-1-yl)propyl]pentyl}glycinamide
      
    
    
    
    
      
        Order
      
      33839-54-2
      
        N~2~,N~2~-diethyl-N-{2-(naphthalen-1-yl)-2-[2-(pyrrolidin-1-yl)ethyl]pentyl}glycinamide
      
    
    
    
                    
  
  
  
  
  
  
  
  
                33834-74-1,33836-52-1,33837-41-1,3383-74-2,33838-32-3,33838-34-5 Supplier | KINGPHARM.GROUP
            CMO CDMO service. KINGPHARM.GROUP supply 33834-74-1,33836-52-1,33837-41-1,3383-74-2,33838-32-3,33838-34-5 and related compounds.
            
                    33836-52-1
                    33837-41-1
                    3383-74-2
                    33838-32-3
                    33838-34-5
                    33834-74-1